(Q43049230)

12 November 2017

title

Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial (English)

1 reference

Japanese encephalitis virus

12 November 2017

main subject

0 references

placebo

1 reference

inferred from title

Japanese encephalitis

1 reference

1 reference

12

1 reference

12 November 2017

11

Nicholas J White

1 reference

12 November 2017

3

Bridget Wills

1 reference

12 November 2017

Tom Solomon

1

0 references

David W Vaughn

10

object named as

David W Vaughn

1 reference

12 November 2017

4

Rachel Kneen

1 reference

12 November 2017

Nguyen Minh Dung

2

1 reference

12 November 2017

Mary Gainsborough

5

1 reference

12 November 2017

Tran Vinh Diet

6

1 reference

12 November 2017

Tran Thi Nhu Thuy

7

1 reference

12 November 2017

Ha Thi Loan

8

1 reference

12 November 2017

Vo Cong Khanh

9

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

12 November 2017

number of pages

6

1 reference

inferred from page(s)

published in

The Lancet

1 reference

12 November 2017

volume

361

1 reference

12 November 2017

issue

9360

1 reference

12 November 2017

page(s)

821-826

1 reference

Emerging arboviral encephalitis. Newsworthy in the West but much more common in the East

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

New initiatives for the control of Japanese encephalitis by vaccination: minutes of a WHO/CVI meeting, Bangkok, Thailand, 13-15 October 1998.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Poliomyelitis-like illness due to Japanese encephalitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Dengue and other emerging flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Effect of High-Dose Dexamethasone on the Outcome of Acute Encephalitis Due to Japanese Encephalitis Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Levels of interferon in the plasma and cerebrospinal fluid of patients with acute Japanese encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Surgical reconstruction of TMJ

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Neurological manifestations of dengue infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Assessment of coma and impaired consciousness. A practical scale

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Intraleucocytic malaria pigment and prognosis in severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Distribution of alpha interferon in serum and cerebrospinal fluid after systemic administration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Failure of interferon alfa and tribavirin in rabies encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2912709-2

7 January 2021

10.1016/S0140-6736(03)12709-2

Identifiers

DOI

1 reference

12 November 2017

1 reference